Abu Dhabi: The second edition of the Mediclinic Abu Dhabi Annual Cancer Conference has kicked off, featuring 18 different speakers from the UAE and from Mediclinic’s sister division in Switzerland, Hirslanden.
Held under the patronage of Sheikh Nahyan bin Mubarak Al Nahyan, Minister of Tolerance and Coexistence, and with the support of the Department of Health in Abu Dhabi, the one-day event discussed diverse topics and saw the attendance of more than 250 medical professionals working in the field of oncology from across the UAE.
The conference underscores the fact that Abu Dhabi has emerged as a regional and global centre of excellence for health care. Regarding the scourge of cancer, we strive to attain the most advanced technologies, detect the disease as early as possible, implement the most effective treatments and cures, produce research that is relevant to our region, improve cancer education and awareness, and empower all segments of society to support cancer patients and their families. The annual conference is certainly an important contributor to that effort.
Sheikh Nahyan commented.
“The focus of this conference on a “multi-disciplinary approach to cancer” reflects the latest strategies for fighting the disease. Innovations such as nanotechnology, T-cell therapy, radiotherapy, chemotherapy, precision medicine, cancer vaccines, artificial intelligence, and robotic surgery are helping to prolong lives and energise the fight against this dreaded disease,” Sheikh Nahyan further remarked.
Mr. Hein Van Eck, Chief Executive Officer at Mediclinic Middle East, stated that “oncology is an ever-evolving and continuously progressing field; therefore, it is of paramount importance that professionals in these areas of medicine stay abreast of the latest new evidence, research findings, and tools to provide world-class cancer treatments to the communities in which we operate. This educational initiative is also in line with our mission to ensure the safety of the community by raising awareness of public and preventative health.”
“The conference is a testament to the efforts being exerted by all stakeholders to work collectively to combat cancer and promote screening, which leads to early detection of the disease and results in better clinical outcomes,” the CEO added.